Company: ELV
Filing Date: 2025-07-17
Form Type: 10-Q
Source: 0001156039-25-000114
Chunk: 48

Company: Elevance Health, Inc.
Filing Date: 2025-07-17
Form: 10-Q
Item: Item 8
Chunk 48
---
 $11,609 $11,609 $18 $(9,489)$72,018 Cost of products sold— 19,168 — 19,168 — (8,892)10,276 Operating expense9,356 453 1,477 1,930 590 (1,579)10,297 Operating gain (loss)$3,777 $1,138 $891 $2,029 $(211)$— $5,595 Six Months Ended June 30, 2024Premiums$70,478 $— $1,202 $1,202 $— $(568)$71,112 Product revenue— 10,029 — 10,029 — — 10,029 Service fees3,939 2 393 395 21 — 4,355 Operating revenue - unaffiliated74,417 10,031 1,595 11,626 21 (568)85,496 Operating revenue - affiliated— 6,810 6,959 13,769 228 (13,997)— Operating revenue - total$74,417 $16,841 $8,554 $25,395 $249 $(14,565)$85,496 Benefit expense$60,937 $— $6,642 $6,642 $10 $(6,471)$61,118 Cost of products sold— 15,413 — 15,413 — (6,768)8,645 Operating expense9,048 408 1,414 1,822 408 (1,326)9,952 Operating gain (loss)$4,432 $1,020 $498 $1,518 $(169)$— $5,781 A reconciliation of reportable segments’ operating revenue to the amounts of total revenues included in our consolidated statements of income for the three and six months ended June 30, 2025 and 2024 is as follows: Three Months Ended  June 30Six Months Ended  June 30 2025202420252024Reportable segments’ operating revenue$49,421 $43,223 $98,186 $85,496 Net investment income486 508 1,076 973 Net losses